Author: Business Wire

Visus Therapeutics Appoints Ophthalmology Expert David Guyer, M.D., as Chairman of the Board and Welcomes Seasoned Life Sciences Executive Ted Danse as Head of Business Development

SEATTLE–(BUSINESS WIRE)–Visus Therapeutics Inc., a clinical-stage pharmaceutical company developing innovative ophthalmic therapies to improve vision for people around the world, today announced the appointment of ophthalmology and industry expert Da…